China Resources Pharmaceutical (03320.HK): China Resources Double-Crane's net profit for the first three quarters was approximately RMB 1.307 billion, a year-on-year decrease of 6.51%.

Zhitong Finance APP news, China Resources Pharmaceutical (03320.HK) announced the first three quarters of 2026 results for China Resources Double-Crane, with total operating revenue of approximately RMB 8.066 billion, a year-on-year decrease of 4%; net profit of approximately RMB 1.307 billion, a year-on-year decrease of 6.51%.